Medicinal product name Atazanavir Mylan
Pharmaceutical form Capsule, hard
Strength 300 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code J05AE08 Antivirals for systemic use

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(300 mg)
HDPE bottle 345.90  EU/1/16/1091/009  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/16/1091/009
Date of authorisation Aug 22, 2016
Marketing authorisation holder, country Mylan Pharmaceuticals Limited, Ireland